Stroth et al., 2015 - Google Patents
S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behaviorStroth et al., 2015
View DOC- Document ID
- 11438652063504078638
- Author
- Stroth N
- Svenningsson P
- Publication year
- Publication venue
- European Neuropsychopharmacology
External Links
Snippet
Abstract The serotonin 5-HT 7 receptor (5-HT 7) is an emerging target for psychiatric pharmacotherapy. Recent observations in rodent models and humans suggest that its blockade mediates antidepressant efficacy. In the present study, we identify the Ca 2+ …
- 101700036203 S100B 0 title abstract description 132
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stroth et al. | S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior | |
Tyagarajan et al. | Gephyrin: a master regulator of neuronal function? | |
Navarro et al. | Ion channels that control fertility in mammalian spermatozoa | |
Kuang et al. | Cloning and characterization of a family C orphan G‐protein coupled receptor | |
Beech | Orai1 calcium channels in the vasculature | |
Chai et al. | Hedgehog signaling acts with the temporal cascade to promote neuroblast cell cycle exit | |
Bondi et al. | Glutamatergic animal models of schizophrenia | |
Matosin et al. | Shifting towards a model of mGluR5 dysregulation in schizophrenia: consequences for future schizophrenia treatment | |
Yu-Taeger et al. | Impaired dopamine-and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia | |
Chuykin et al. | Par3 interacts with Prickle3 to generate apical PCP complexes in the vertebrate neural plate | |
Simske | Claudins reign: The claudin/EMP/PMP22/γ channel protein family in C. elegans | |
WO2012065182A2 (en) | Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders | |
Suwa et al. | Distribution of serotonin 4 (a) receptors in the juvenile rat brain and spinal cord | |
Tanaka et al. | Melatonin signaling regulates locomotion behavior and homeostatic states through distinct receptor pathways in Caenorhabditis elegans | |
Lee et al. | A new splice variant of the glutamate–aspartate transporter: Cloning and immunolocalization of GLAST1c in rat, pig and human brains | |
Muthusamy et al. | Complementary roles of the neuron‐enriched endosomal proteins NEEP21 and calcyon in neuronal vesicle trafficking | |
Fu et al. | miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice | |
Lee et al. | Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila | |
Dewa et al. | Neuronal DSCAM regulates the peri-synaptic localization of GLAST in Bergmann glia for functional synapse formation | |
Yoon et al. | cAMP Signaling–Mediated Phosphorylation of Diacylglycerol Lipase α Regulates Interaction With Ankyrin-G and Dendritic Spine Morphology | |
Ding et al. | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture | |
Saunders et al. | Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function | |
Zhou et al. | Replication protein a links cell cycle progression and the onset of neurogenesis in Drosophila optic lobe development | |
Sun et al. | Crybb2 associates with Tmsb4X and is crucial for dendrite morphogenesis | |
Valenti et al. | The increase in maternal expression of axin1 and axin2 contribute to the zebrafish mutant ichabod ventralized phenotype |